TY - JOUR
T1 - A guide to the use of bioassays in exploration of natural resources
AU - Sabotič, Jerica
AU - Bayram, Engin
AU - Ezra, David
AU - Gaudêncio, Susana P.
AU - Haznedaroğlu, Berat Z.
AU - Janež, Nika
AU - Ktari, Leila
AU - Luganini, Anna
AU - Mandalakis, Manolis
AU - Safarik, Ivo
AU - Simes, Dina
AU - Strode, Evita
AU - Toruńska-Sitarz, Anna
AU - Varamogianni-Mamatsi, Despoina
AU - Varese, Giovanna Cristina
AU - Vasquez, Marlen I.
N1 - Funding Information:
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04326%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04326%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0101%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04378%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04378%2F2020/PT#
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/LA%2FP%2F0140%2F2020/PT#
This publication is based upon work from COST Action CA18238 (Ocean4Biotech), supported by COST (European Cooperation in Science and Technology) program .
Funding Information:
Research of Dina Simes was funded by the Portuguese National Funds from FCT—Foundation for Science and Technology , through projects UIDB/04326/2020 , UIDP/04326/2020 and LA/P/0101/2020 and AAC n° 41/ALG/2020 - Project n° 072583 – NUTRISAFE.
Funding Information:
Research of Evita Strode was supported by ERDF post-doctoral research grant 1.1.1.2/16/I/001 (application No 1.1.1.2/VIAA/3/19/465).
Funding Information:
Susana P. Gaudêncio: This work is financed by national funds from FCT - Fundação para a Ciência e a Tecnologia , I.P., in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB .
Funding Information:
Research of Jerica Sabotič and Nika Janež was supported by Slovenian Research Agency ( J4- 2543 , J4-4555 , P4-0127 , P4-0432 ).
Funding Information:
Research of Anna Luganini and Giovanna Cristina Varese was financed by the University of Torino (Ricerca Locale) and the European Commission – NextGenerationEU , Project “Strengthening the MIRRI Italian Research Infrastructure for Sustainable Bioscience and Bioeconomy”, code n. IR0000005.
Funding Information:
Research of David Ezra was supported by The Chief Scientist of the Israeli Ministry of Agriculture and Rural Development (MOARD), grant number 20-02-0122 , and Copia Agro Israel.
Publisher Copyright:
© 2024 The Authors
PY - 2024/3
Y1 - 2024/3
N2 - Bioassays are the main tool to decipher bioactivities from natural resources thus their selection and quality are critical for optimal bioprospecting. They are used both in the early stages of compounds isolation/purification/identification, and in later stages to evaluate their safety and efficacy. In this review, we provide a comprehensive overview of the most common bioassays used in the discovery and development of new bioactive compounds with a focus on marine bioresources. We present a comprehensive list of practical considerations for selecting appropriate bioassays and discuss in detail the bioassays typically used to explore antimicrobial, antibiofilm, cytotoxic, antiviral, antioxidant, and anti-ageing potential. The concept of quality control and bioassay validation are introduced, followed by safety considerations, which are critical to advancing bioactive compounds to a higher stage of development. We conclude by providing an application-oriented view focused on the development of pharmaceuticals, food supplements, and cosmetics, the industrial pipelines where currently known marine natural products hold most potential. We highlight the importance of gaining reliable bioassay results, as these serve as a starting point for application-based development and further testing, as well as for consideration by regulatory authorities.
AB - Bioassays are the main tool to decipher bioactivities from natural resources thus their selection and quality are critical for optimal bioprospecting. They are used both in the early stages of compounds isolation/purification/identification, and in later stages to evaluate their safety and efficacy. In this review, we provide a comprehensive overview of the most common bioassays used in the discovery and development of new bioactive compounds with a focus on marine bioresources. We present a comprehensive list of practical considerations for selecting appropriate bioassays and discuss in detail the bioassays typically used to explore antimicrobial, antibiofilm, cytotoxic, antiviral, antioxidant, and anti-ageing potential. The concept of quality control and bioassay validation are introduced, followed by safety considerations, which are critical to advancing bioactive compounds to a higher stage of development. We conclude by providing an application-oriented view focused on the development of pharmaceuticals, food supplements, and cosmetics, the industrial pipelines where currently known marine natural products hold most potential. We highlight the importance of gaining reliable bioassay results, as these serve as a starting point for application-based development and further testing, as well as for consideration by regulatory authorities.
KW - Bioactivity
KW - Bioactivity-guided purification
KW - Bioassay selection
KW - Biodiscovery
KW - Blue biotechnology
KW - Drug discovery
KW - Natural products
KW - Preclinical trials
KW - Validation
UR - http://www.scopus.com/inward/record.url?scp=85183459363&partnerID=8YFLogxK
U2 - 10.1016/j.biotechadv.2024.108307
DO - 10.1016/j.biotechadv.2024.108307
M3 - Review article
C2 - 38185432
AN - SCOPUS:85183459363
SN - 0734-9750
VL - 71
JO - Biotechnology Advances
JF - Biotechnology Advances
M1 - 108307
ER -